Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Caring & giving/
  4. Bridge to Employment: 25 years of helping young people excel in school—and life
A photo of a group from Bridge to Employment

Bridge to Employment: 25 years of helping young people excel in school—and life

This Johnson & Johnson program pairs high school kids with local companies and institutes of higher learning to help set them up for success in the work world. We take a look at the inspiring statistics behind that success.

Since 1992, Johnson & Johnson’s Bridge to Employment (BTE) program has provided high schoolers with meaningful educational experiences and career prep to help set them up for success as they head off to college.

In the last 25 years, BTE has come a long way: What started as a U.S.-based program has expanded well beyond its domestic roots to encompass over 80 sites in more than 20 countries, including India, Israel, Mexico, South Africa and Spain.

Earlier this year, in fact, Johnson & Johnson India was honored with the prestigious Global CSR Leadership Award for Innovation in Corporate Social Responsibility Practices for its work mentoring 50 underprivileged students in Mumbai through the BTE program.

As the latest class of students graduates from the program on June 21, we’re taking a look at the impact BTE has had over the last quarter-century around the globe.


Johnson & Johnson’s Bridge to Employment Program

More from Johnson & Johnson

6 things to know now about colorectal cancer

Colorectal cancer is now the leading cause of U.S. cancer deaths among people under 50, and rates of the disease are rising globally, too. For Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.

“My company makes the medication that helped me fight multiple myeloma”

Paul Reidy, a Johnson & Johnson warehouse technician in Ireland, never imagined that an oncology therapy made at the facility where he works would help save his life.

What is wAIHA?

Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.